To characterize the developmental changes in adipose and muscle lipoprotein lipase (LPL) activity in the atherosclerosis-prone JCR:LA-corpulent rat, and to test the hypothesis that tissue-specific abnormalities in LPL activity precede the establishment of obesity. DESIGN: Lean ( þ =?) and obese cp=cp male JCR:LA rats were studied at 4, 5 and 8 weeks of age, that is at the onset of obesity, and at a time when obesity is well established. Assessment was made of plasma variables related to glucose and lipid metabolism and of LPL activity in several adipose depots, skeletal muscles and the heart. RESULTS: At week 4, body weights were identical in both genotypes and began to diverge at week 5. Eight-week-old cp=cp rats weighed 35% more than their lean counterparts. Perirenal and epididymal adipose depot weights were also identical in both genotypes at week 4 and began to increase in cp=cp rats at week 5, whereas the subcutaneous depot of 4-week-old cp=cp rats was slightly enlarged. At week 4, the cp=cp rats were hyperinsulinemic (5-fold), hyperleptinemic (30-fold) and hypertriglyceridemic (3-fold) compared to their lean counterparts, and their liver contained twice as much triglyceride. The 4-week-old cp=cp rats displayed 2 -7-fold higher LPL specific activity in the various adipose depots compared to lean rats, and enzyme activity remained higher in obese than in lean rats at all subsequent ages. In contrast, LPL activity in the vastus lateralis, gastrocnemius and heart muscles of 4-week-old obese rats was approximately half that observed in lean animals. CONCLUSION: Profound, persistent alterations in the tissue-specific modulation of LPL activity are established in the JCR:LA cp=cp rat prior to the development of frank obesity. The increase in adipose tissue LPL activity and its decrease in muscle tissues are likely to be related to the concomitant alterations in insulinemia and triglyceridemia, respectively. The pre-obesity, tissuespecific alterations in LPL activity may be considered as an integrated adaptation to increased lipid flux aimed at driving lipids toward storage sites and limiting their uptake by triglyceride-laden muscles.
Introduction
Obesity is typically associated with a cluster of metabolic abnormalities termed the insulin resistance syndrome, or syndrome X, which comprises insulin resistance of glucose metabolism, hyperinsulinemia, dyslipidemia and hypertension. 1 -3 These metabolic abnormalities include alterations in the tissue-specific modulation of lipoprotein lipase (LPL, EC 3.1.1.34), 2 the enzyme that is rate-limiting for the removal of lipoprotein triglycerides (TG) from the circulation and which controls the routing of their constituent fatty acids toward storage or oxidizing tissues. 4 Lipoprotein lipase activity is chronically increased in adipose depots of obese humans 4 and of genetic animal models of obesity, such as the Zucker (fa=fa) rat, 5, 6 whereas that in muscle is unchanged or tends to be reduced. 5 Therefore, alterations in tissue LPL could constitute a permissive factor in the development or maintenance of obesity through increased channeling of lipids to adipose tissue. For instance, compounds such as thiazolidenediones, used to improve insulin sensitivity, but which promote fat deposition, act through increasing adipose LPL activity and reducing fatty acid output from adipose tissue. 7 The mechanisms whereby LPL activity is chronically altered in obesity remain incompletely understood. Among the many endocrine factors that modulate LPL, 4 insulin is a major determinant of adipose tissue LPL activity, and hyperinsulinemia frequently accompanies obesity. In the absence of hyperphagia in obese Zucker (fa=fa) rats, hyperinsulinemia and increased LPL activity are not prevented, 8 whereas recent studies from this laboratory have shown that short-term lowering of insulinemia in the obese Zucker rat decreases LPL activity to lean levels independently of fat mass. 9, 10 These findings support the notion that hyperinsulinemia is the cause of high adipose tissue LPL, at least in this model of obesity. Obese humans and animal models also present with hyperleptinemia and leptin resistance. Leptin, the product of the ob gene which is expressed predominantly in adipose tissue, reduces appetite and increases energy expenditure in rodents bearing mutations in the gene coding for leptin. 11 Leptin is also thought to exert peripheral actions, particularly on insulin sensitivity and pancreatic insulin secretion, 12, 13 and could therefore be involved in some of the defects in insulin homeostasis and its metabolic consequences associated with obesity.
Rodent models of obesity with genetic defects in the ob gene or the leptin receptor, including the ob=ob mouse, the diabetic db=db mouse and the Zucker fatty (fa=fa) rat, all develop multiple metabolic disorders similar to those observed in human obesity and insulin resistance syndrome. 8, 11, 14 However, these genetically obese rodents do not develop myocardial disease or marked atherosclerosis. 15, 16 The JCR:LA-corpulent (cp) rat bears the autosomal recessive cp gene originally isolated by Koletsky. 17 Male rats homozygous for the cp gene lack the leptin receptor, 18 are severely obese and display the metabolic abnormalities typical of the insulin resistance syndrome. 19, 20 The JCR:LA-cp rat is unique because it is the only one of five major strains with the cp gene to develop atherosclerotic and myocardial lesions from an early age. 15, 21 Hyperlipidemia, insulin resistance, hyperinsulinemia and=or impaired glucose tolerance appear to be necessary for the induction of the vascular and myocardial lesions in the JCR:LA-cp rats, none being sufficient in itself. 22 The present study aimed to characterize the changes in LPL activity that occur in storage (white adipose) and oxidative tissues (skeletal and cardiac muscle) before and during the early phase of obesity development in the JCR:LA-cp rat. The hypothesis to be tested was that, before the establishment of frank obesity, the lack of leptin action brings about hyperinsulinemia, which in turn increases adipose LPL and decreases muscle LPL activity, thereby creating conditions that favor the routing of lipid substrates toward storage. To this end, þ =? and cp=cp rats of the JCR:LA-cp strain were studied at 4, 5 and 8 weeks of age, that is at the onset of obesity, and at a time when obesity is well established. 19 In addition to leptinemia and insulinemia, an assessment was made of changes in plasma levels of energy substrates (glucose, nonesterified fatty acids (NEFA)), as well as those in hepatic TG content and plasma levels of TG as indicators of endogenous TG production and transport, respectively.
Material and methods

Animals
Lean ( þ =?) and obese (cp=cp) male JCR:LA-cp rats 4, 5 and 8 weeks of age were bred in an established colony at the University of Alberta, as previously described. 23 They were housed individually in polycarbonate cages on wood-chip bedding at 20 AE 1 C with lights on from 6:00 am to 6:00 pm. Throughout the experiment, the animals had ad libitum access to water and food (Lab diet 5001, PMI Nutrition International, Brentwood, MO, USA). The latter is a grainbased diet of under 4% total lipid content by weight. 24 All care, treatment and handling of the rats were in conformity with the guidelines of the Canadian Council on Animal Care and subject to prior institutional review and approval. The animals were randomly assigned to six groups according to a 2Â3-factorial design. The factors were Genotype with two levels (lean and obese), and Age with three levels (4, 5 and 8 weeks).
Blood and tissue harvesting At 4, 5 and 8 weeks of age, in the morning after normal night access to food, rats were anesthetized with halothane, and blood collected by heart puncture was centrifuged at 1500 g, 4 C, for 15 min. Plasma was stored at 7 70 C for later biochemical measurements. A liver sample was taken and stored at 7 70 C for later lipid extraction by the method of Folch et al 25 and quantitation of liver TG content as described below. Perirenal, epididymal and subcutaneous (inguinal) white adipose tissue (WAT), as well as red vastus lateralis muscle (VLM), gastrocnemius and the heart were excised. Tissues were weighed, approximately 50 mg were taken from WAT, the red portion of VLM and gastrocnemius, as well as the apex of the heart, and tissue samples were homogenized using all-glass tissue grinders (Kontes, Vineland, NJ, USA). The WAT samples were homogenized in 1 ml of a solution containing 0.25 M sucrose, 1 mM EDTA, 10 mM Tris -HCL, and 12 mM deoxycholate, pH 7.4. The VLM, gastrocnemius and heart samples were homogenized in 1 ml of a solution containing 1 M ethylene glycol, 50 mM Tris -HCL, 3 mM deoxycholate, 10 IU=ml heparin, and 5% (v=v) aprotinin (Trasylol, Miles Pharmaceuticals, Rexdale, Ontario, Canada), pH 7.4. These homogenizing media were found to yield optimal LPL activities in the individual tissues. Homogenates of VLM, gastrocnemius and the heart were quickly frozen and stored at 7 70 C until measurement of LPL activity. WAT homogenates were centrifuged at 12000 G, 4 C, for 20 min. The fraction between the upper fat layer and the bottom sediment was removed after tube slicing, diluted with 4 vols of the homogenization solution Lipoprotein lipase in the JCR:LA-cp rat L Mantha et al without deoxycholate, and stored at 7 70 C until LPL measurements.
Plasma and liver variables
Plasma insulin and leptin were quantitated by radioimmunoassay using reagent kits from Linco Research Inc. (St Charles, MO, USA) with rat insulin and leptin as standards. Plasma glucose levels were quantitated by the glucose oxidase method using the Beckman Glucose Analyzer (Beckman Instruments, Palo Alto, CA, USA). Plasma and liver TG concentrations were assayed by an enzymatic method with the use of a reagent kit from Boehringer Mannheim (Montréal, Québec, Canada), which allows correction for free glycerol. Plasma NEFA concentrations were determined enzymatically with a reagent kit from Wako Pure Chemical Industries (Richmond, VA, USA).
Tissue LPL activity LPL activity was measured in tissue homogenates as described earlier. 26 Samples of 100 ml of tissue homogenates were incubated for 1 h at 28 C under gentle agitation with 100 ml of a substrate mixture consisting of a 0.2 M Tris -HCL buffer, pH 8.6, which contained 10 MBq=l [carboxyl- 14 C] triolein and 2.52 mM cold triolein emulsified in 5% gum arabic, as well as 2% fatty-acid free bovine serum albumin, 10% human serum as a source of apolipoprotein C-II, and either 0.2 or 2 M NaCl. Oleate released by LPL was then separated from intact triolein using a liquid partition system, 27 mixed with Universol (New England Nuclear, Montréal, Québec, Canada), and sample radioactivity was determined in an LKB Rackbeta liquid scintillation counter. LPL activity was calculated by subtracting non-LPL lipolytic activity determined in a final NaCl concentration of 1 M from total lipolytic activity determined in a final NaCl concentration of 0.1 M. In the present conditions, 1 M NaCl inhibited 82 -91% of total lipolytic activity in all tissue homogenates. Tissue LPL activity was expressed as munits (1mU ¼ 1 mmol NEFA released per hour of incubation at 28 C). The interassay coefficient of variation was 4.8% and was determined using bovine skim milk as a standard source of LPL. Protein content of the tissue extracts was determined by the method of Lowry et al. 28 Because of the large betweengenotype differences in tissue weights, LPL activity was expressed per unit tissue protein (specific activity). Activity was also expressed per total adipose depot and muscle to highlight the overall tissue-specific availability of LPL.
Statistical analysis
Data are expressed as means AE s.e.m. To assess the effects of genotype and age on plasma variables and on WAT and muscle LPL activities, the data were analyzed by factorial analysis of variance, the factors being Genotype with two levels (lean, obese) and Age with three levels (4, 5, 8 weeks of age). When justified by a significant treatment interaction, pairwise between-group comparisons were performed using post hoc Fisher's protected least squares difference test to locate the interaction. Data were log transformed before analysis when group variances were not homogeneous (O'Brien's test), but untransformed values are presented below. Differences were considered statistically significant at P < 0.05.
Results
The effects of genotype and age on final body weight, plasma glucose, NEFA, insulin, leptin and TG concentrations as well as liver TG content are presented in Table 1 . Genotype and age exerted main and interactive effects on final body weight. At 4 weeks of age, þ =? and cp=cp rats had identical body weights, whereas at 5 and 8 weeks of age, body weight of the cp=cp rats was significantly elevated compared to their lean counterparts. Genotype and age also interacted on glycemia. Post hoc analysis revealed that cp=cp rats 8 weeks of age were slightly hyperglycemic relative to the 4-week-old rats and their 8-week-old lean Values represent means AE s.e. of five or six animals. The ANOVA columns depict levels of significance of main effects of genotype (G) with two levels (lean, obese) and Age (A) with three levels (4, 5, 8 weeks), and those of treatment interaction (GÂA). When justified by a significant factor interaction, individual between-group comparisons were made. In this case, means not sharing the same superscript are different from each other (P < 0.05). NS not significant.
Lipoprotein lipase in the JCR:LA-cp rat L Mantha et al Table 1 footnote for significance of ANOVA table. Table 1 footnote for significance of ANOVA table.
Lipoprotein lipase in the JCR:LA-cp rat L Mantha et al counterparts. Plasma concentrations of NEFA, which partly determine rates of hepatic TG synthesis, were found to increase with time. NEFA tended to be higher in obese than in lean animals at 8 weeks of age, but genotype and time did not interact on this variable. The cp=cp rats were hyperinsulinemic compared to lean animals at all ages, and plasma insulin levels increased with age. Insulinemia of the 4-week-old obese rats was 5-fold higher than that of lean animals. Genotype interacted with age on leptinemia. Plasma leptin levels remained essentially the same at all ages in lean rats, whereas leptin was higher at weeks 5 and 8 than at week 4 in the obese animals. The cp=cp rats 4 weeks of age displayed marked hyperleptinemia (30-fold) compared to their lean counterparts, at a time when obesity was not established. Genotype and age interacted on plasma levels of TG, as with time, a significant increase in plasma TG concentrations was observed only in the obese animals. Three-to 5-fold higher TG levels were observed in cp=cp rats at all ages compared to lean values. Hepatic TG content was quantitated as an index of long-term liver TG accumulation. Genotype and age interacted on liver TG content, inasmuch as the genotype-related difference appeared to be smaller at week 5 than at the other time points. Globally, time alone did not affect liver TG, which was higher in obese than in lean animals at all time points. Genotype and age interacted significantly on perirenal ( Figure 1A ), epididymal (Figure 2A) , and subcutaneous ( Figure 3A ) fat mass. Four-week-old cp=cp rats had slightly more subcutaneous fat mass than their lean counterparts, whereas perirenal and epididymal depots were identical in both genotypes. Genotype-related differences in the weight of all three depots were clearly established at week 5 and were further amplified at week 8. Genotype and age interacted significantly on perirenal adipose LPL specific ( Figure  1B ) and total ( Figure 1C ) activity. LPL activity was 4-fold higher in the 4-week-old cp=cp rats compared to their lean counterparts. The genotype-related difference in LPL activity expressed per unit protein declined with time because of a reduction in LPL specific activity in the obese animals, but increased with time when LPL per total depot was considered (10-fold difference between genotypes at week 8). Epididymal LPL specific activity was consistently higher in the cp=cp rats when compared to þ =? animals ( Figure 2B ). LPL specific activity in this depot increased until 5 weeks in both þ =? and cp=cp animals, and then declined at week 8. On a total tissue basis ( Figure 2C ), LPL activity increased with time in Figure 3 Subcutaneous adipose tissue weight (A), specific (B; LPL s), and total LPL activity (C; LPL t) in þ =? lean (hatched bars) and cp=cp obese rats (filled bars) at 4, 5 and 8 weeks of age. Bars represent means AE s.e. of five or six animals. See Table 1 footnote for significance of ANOVA table.
Lipoprotein lipase in the JCR:LA-cp rat L Mantha et al both genotypes, but to a much larger extent in the cp=cp animals. Total LPL was already 2-fold higher in the epididymal depot of the cp=cp than in that of the þ =? rats at week 4, a difference that reached 6-fold at week 8. In the subcutaneous depot, LPL specific activity was 7-fold greater in 4-week-old cp=cp rats compared to their þ =? counterparts, with no further absolute or relative change with time ( Figure 3B ). When expressed per total depot ( Figure 3C ), LPL activity in the subcutaneous depot increased with time in both genotypes, but more so in the cp=cp than in the þ =? rats. Genotype-related differences in total subcutaneous adipose LPL activity grew from 12-to 21-fold between weeks 4 and 8. Heart weight was similar in both genotypes at weeks 4 and 5, but slightly ( þ 21%) larger in 8-week-old obese than in lean rats ( Figure 4A ). Heart LPL specific activity declined with age, whereas at all ages studied, cp=cp rats had lower ( $ 50%) LPL-specific activity than their lean counterparts ( Figure 4B ). Total heart LPL increased with age in both genotypes but remained half as high in cp=cp than in þ =? rats throughout the experimental period ( Figure 4C ). Figure 5A shows that genotype and age interacted on gastrocnemius weight, the interaction stemming from the fact that muscle weight was similar in both genotypes at week 4, but lower in obese than in lean rats thereafter. Genotype and age also interacted on gastrocnemius LPL specific activity ( Figure 5B ). The latter was 50% lower in 4-week-old cp=cp rats compared to lean animals, a difference that tended to be attenuated subsequently because of a lowering of LPL specific activity with time in lean animals. LPL activity per total muscle increased gradually along with muscle weight as the animals aged, but was consistently lower in obese than in lean animals ( Figure  5C ). Similar main and interactive genotype and age effects were noted in the vastus lateralis muscle (Figure 6) , with somewhat more marked genotype-related differences than in the gastrocnemius.
Discussion
This study examined developmental changes in LPL activity in adipose and muscle of the atherosclerosis-prone JCR:LAcorpulent rat. Within the first week after weaning, adipose tissue LPL specific activity was 3 -10-fold higher and muscle LPL 50% lower in cp=cp than in þ =? rats. At this time body weight did not differ between genotypes and adipose tissue depots had barely begun to increase in cp=cp rats. These Figure 4 Heart weight (A), specific (B; LPL s), and total LPL activity (C; LPL t) in þ =? lean (hatched bars) and cp=cp obese rats (filled bars) at 4, 5 and 8 weeks of age. Bars represent means AE s.e. of five or six animals. See Table 1 footnote for significance of ANOVA table.
Lipoprotein lipase in the JCR:LA-cp rat L Mantha et al Figure 5 Gastrocnemius muscle weight (A), specific (B; LPL s), and total LPL activity (C; LPL t) in þ =? lean (hatched bars) and cp=cp obese rats (filled bars) at 4, 5 and 8 weeks of age. Bars represent means AE s.e. of five or six animals. See Table 1 footnote for significance of ANOVA table. Figure 6 Vastus lateralis muscle weight (A), specific LPL (B; LPL s), and total LPL activity (C; LPL t) in þ =? lean (hatched bars) and cp=cp obese rats (filled bars) at 4, 5 and 8 weeks of age. Bars represent means AE s.e. of five or six animals. See Table 1 footnote for significance of ANOVA table. Lipoprotein lipase in the JCR:LA-cp rat L Mantha et al tissue-specific differences in LPL activity between genotypes were retained during later development of obesity. Hyperphagia occurs within the first week post-weaning in the JCR:LA cp=cp rat. 19 The increase in energy intake is not, however, reflected in a significant increase in body weight until 2 weeks after weaning (week 5), as confirmed in the present study. Except for subcutaneous fat, all adipose depots and muscles examined had similar mass in lean and obese animals at week 4. Obesity develops earlier in the JCR:LA than in the Zucker rat, 29 probably because of the earlier onset of hyperphagia.
Hypertriglyceridemia is among the earliest metabolic abnormalities in cp=cp rats, and develops prior to glucose intolerance. 19 In the present study, cp=cp rats were hypertriglyceridemic as early as 1 week after weaning. Several factors are probably responsible for this dyslipidemia. Firstly, hyperphagia that is already established at 4 weeks of age undoubtedly contributes to increased plasma TG, by providing increased dietary fat, as well as carbohydrate precursors for liver lipogenesis. Liver TG content of the cp=cp animals indicates increased hepatic TG accumulation as early as 4 weeks. The contribution of fatty acids from adipose tissue to the liver did not appear to be enhanced in the cp=cp animals in the early development of obesity, since plasma NEFA levels did not increase until week 8. Increased liver lipid production in cp=cp rats is accompanied by hypersecretion of VLDL, 30 a process that may become exacerbated by hepatic insulin resistance and decreased inhibition of VLDL secretion by insulin. 31 Secondly, reduced muscle LPL activity, if not fully compensated by high LPL activity in adipose tissue, may also contribute to hypertriglyceridemia. Low postheparin plasma LPL activity, which constitutes the global intravascular availability of LPL, has been observed in obese humans. 3 Thirdly, VLDL may be of abnormal composition, which would render the particles less suitable for TG hydrolysis by LPL, as shown in the Wistar fatty rat. 32 Finally, dysregulation of hepatic lipid metabolism secondary to the lack of central leptin action cannot be ruled out a priori.
Moderate hyperinsulinemia was already present at 4 weeks of age in the cp=cp rats, reflecting decreased sensitivity to insulin-stimulated glucose uptake. At 8 weeks there was no insulin-stimulated glucose uptake even at supra-physiological insulin concentrations. 19 Part of the hyperinsulinemia in the cp=cp rat probably results from the complete absence of leptin's inhibitory action on insulin secretion. 33, 34 The cp=cp rats also eliminate insulin at a slower rate than their lean counterparts. 35 Over the study period, plasma leptin levels were positively correlated with the sum of adipose tissue weights (data not shown), confirming results in humans and rodents. 36, 37 However, this is the first report of hyperleptinemia preceding the development of frank obesity in the cp=cp rat, which corroborates findings in the fa=fa model. 38 Shillabeer et al 39 showed in 8-month-old cp=cp rats that adipose leptin mRNA levels, even when reduced by food intake restriction, remained 2-fold higher than in lean animals. The present findings indicate that hyperleptinemia precedes the development of marked obesity in cp=cp rats. Such disproportionate leptinemia in the 4-week-old cp=cp animals, given their relatively normal adipose mass, may partly be attributable to the stimulatory action of hyperinsulinemia on leptin secretion by adipose tissue. 40, 41 In obese animals, other possible contributors to hyperleptinemia include hypercorticosteronemia 42 and reduced sympathetic activity. 43 Whether these factors contributed to hyperleptinemia in 4 week-old cp=cp rats without overt obesity remains to be determined.
LPL activity expressed per unit protein increased in all three adipose depots with the development of obesity in cp=cp rats, whereas it remained unchanged in lean animals as they matured. Remarkably, LPL activity in deep abdominal and subcutaneous adipose depots was greatly elevated in the cp=cp animals 4 weeks of age before the appearance of overt obesity. At that time, the sum of total LPL activity in the three depots studied (data not shown) was already 6-fold higher in the cp=cp than in the þ =? rats. Enzyme activity remained higher in the cp=cp than in the þ =? animals from 4 to 8 weeks of age, and the between-genotype difference in the sum of total adipose LPL had reached 10-fold at that later time. High adipose LPL activity early in life is also observed in the Zucker fa=fa rat. 4, 5 This implies that adipose LPL activity does not merely follow adipose tissue growth, but that it constitutes a permissive factor in fat deposition that accomodates the larger dietary and endogenous TG input. It is unlikely that the absence of leptin action in the cp=cp rat is directly involved in LPL modulation, since recent studies reported a lack of effect of leptin on LPL activity and glucose=insulin metabolism in adipocytes and myocytes. 44 There is substantial evidence that elevated adipose LPL in the cp=cp rat results from hyperinsulinemia. Insulin constitutes a robust modulator of adipose tissue LPL activity 4 and it is a necessary and sufficient factor to induce the acute changes in tissue LPL seen in response to food intake. 45 In addition, we recently showed in Zucker fa=fa rats that reduction in insulinemia to lean levels induced by streptozotocin 9 or by fasting 10 reduced adipose tissue LPL activity to that of lean animals. In obese Zucker rats, 10 as well as in rats with insulin resistance induced by a high sucrose=fat diet (Picard F, Boivin A, Lalonde J, Deshaies Y, unpublished observations), LPL is resistant to insulin action as witnessed by the long delay in its postprandial activation following a 24 h fast. However, such resistance is transient (hours), and sustained hyperinsulinemia is accompanied by high adipose LPL activity in obese humans and animal models. 4, 46 Therefore, the early onset of hyperinsulinemia in cp=cp rats is likely to increase adipose tissue LPL activity preceding fat accretion. This does not preclude contributions from additional factors, such as the absence of leptin-induced recruitment of the sympathoadrenal system, which modulates tissue-specific LPL expression oppositely to insulin. 10,47 -49 Cardiac and skeletal muscle LPL activity was reduced at 4 -8 weeks in the cp=cp rats compared to lean counterparts. Lower muscle LPL in insulin-resistant humans was observed Lipoprotein lipase in the JCR:LA-cp rat L Mantha et al in several studies. 5,50 -52 The present work extends the relationship between muscle LPL and obesity=insulin resistance by demonstrating a 50% decrease in cardiac and skeletal muscle LPL that precedes the development of obesity and severe muscle insulin resistance in cp=cp rats. 19 The modulation of LPL activity in muscle tissues is less well defined than that of adipose tissue. Muscle LPL is decreased acutely by insulin in response to feeding. 45 However, long-term modulation of muscle LPL does not appear to be determined directly by insulinemia per se. In Zucker fa=fa rats treated with streptozotocin to decrease insulinemia, the already low muscle LPL was further reduced, rather than increased. 9 However, the latter correlated with increased plasma levels of NEFA and TG. Therefore, whereas muscle LPL acutely responds negatively to insulin, long-term modulation may depend upon the prevailing lipemia. The mechanisms for this are unclear, but high plasma lipid levels increase muscle lipid uptake and high muscle TG content is characteristic of insulin resistance and obesity. 53 -56 The cp=cp rats display high muscle TG concentrations as early as 1 week after weaning, a time when plasma TG, but not NEFA, are elevated, 19 as confirmed in the present study. There is a close association between resistance of glucose metabolism to insulin action and muscle TG content. 53, 54, 56 In addition, plasma and muscle TG appear to be related in cp=cp rats, in which treatment with MEDICA 16, a powerful inhibitor of TG synthesis, reduced both triglyceridemia and muscle TG content. 19 LPL plays an important role in muscle TG accumulation and specific muscle overexpression of LPL increases muscle TG content and muscle-specific insulin resistance. 57 Taken together, these findings suggest that LPL is a plausible link between hypertriglyceridemia, muscle TG accumulation and resulting insulin resistance. The low LPL activity in muscle of cp=cp rats may represent an attempt to limit further TG accumulation in muscle during overt hypertriglyceridemia.
In summary, this study showed that profound, persistent alterations in the tissue-specific modulation of LPL activity occur in the cp=cp rat prior to the development of frank obesity. Increased adipose tissue LPL activity and its decrease in muscles, including the heart, are likely related to concomitant alterations in insulinemia and triglyceridemia, respectively. The pre-obese alterations in LPL activity may be considered as an integrated adaptation to increased lipid flux aimed at driving lipids toward adipose storage sites and limiting their uptake by triglyceride-laden muscles.
